Literature DB >> 21913915

Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects.

Sa'ad Al-Lahham1, Han Roelofsen, Farhad Rezaee, Desiree Weening, Annemieke Hoek, Roel Vonk, Koen Venema.   

Abstract

BACKGROUND: Adipose tissue is a primary site of obesity-induced inflammation, which is emerging as an important contributor to obesity-related diseases such as type 2 diabetes. Dietary fibre consumption appears to be protective. Short-chain fatty acids, e.g. propionic acid, are the principal products of the colonic fermentation of dietary fibre and may have beneficial effects on adipose tissue inflammation.
MATERIALS AND METHODS: Human omental adipose tissue explants were obtained from overweight (mean BMI 28·8) gynaecological patients who underwent surgery. Explants were incubated for 24 h with propionic acid. Human THP-1 monocytic cells were differentiated to macrophages and incubated with LPS in the presence and absence of propionic acid. Cytokine and chemokine production were determined by multiplex-ELISA, and mRNA expression of metabolic and macrophages genes was determined by RT-PCR.
RESULTS: Treatment of adipose tissue explants with propionic acid results in a significant down-regulation of several inflammatory cytokines and chemokines such as TNF-α and CCL5. In addition, expression of lipoprotein lipase and GLUT4, associated with lipogenesis and glucose uptake, respectively, increased. Similar effects on cytokine and chemokine production by macrophages were observed.
CONCLUSION: We show that propionic acid, normally produced in the colon, may have a direct beneficial effect on visceral adipose tissue, reducing obesity-associated inflammation and increasing lipogenesis and glucose uptake. Effects on adipose tissue as a whole are at least partially explained by effects on macrophages but likely also adipocytes are involved. This suggests that, in vivo, propionic acid and dietary fibres may have potential in preventing obesity-related inflammation and associated diseases.
© 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913915     DOI: 10.1111/j.1365-2362.2011.02590.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  53 in total

Review 1.  Effects of gut microbes on nutrient absorption and energy regulation.

Authors:  Rosa Krajmalnik-Brown; Zehra-Esra Ilhan; Dae-Wook Kang; John K DiBaise
Journal:  Nutr Clin Pract       Date:  2012-02-24       Impact factor: 3.080

Review 2.  The microbiome-adipose tissue axis in systemic metabolism.

Authors:  Patrick Lundgren; Christoph A Thaiss
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-18       Impact factor: 4.052

Review 3.  Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.

Authors:  Maksymilian Onyszkiewicz; Kinga Jaworska; Marcin Ufnal
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-16

Review 4.  Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.

Authors:  Jessica Soldavini; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2013-07-10       Impact factor: 3.199

Review 5.  Short-chain fatty acids in control of body weight and insulin sensitivity.

Authors:  Emanuel E Canfora; Johan W Jocken; Ellen E Blaak
Journal:  Nat Rev Endocrinol       Date:  2015-08-11       Impact factor: 43.330

6.  Human adipose tissue from normal and tumoral breast regulates the behavior of mammary epithelial cells.

Authors:  Virginia Pistone Creydt; Sabrina Johanna Fletcher; Jimena Giudice; Ariana Bruzzone; Norma Alejandra Chasseing; Eduardo Gustavo Gonzalez; Paula Alejandra Sacca; Juan Carlos Calvo
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

7.  FLX pyrosequencing analysis of the effects of the brown-algal fermentable polysaccharides alginate and laminaran on rat cecal microbiotas.

Authors:  Choa An; Takashi Kuda; Takahiro Yazaki; Hajime Takahashi; Bon Kimura
Journal:  Appl Environ Microbiol       Date:  2012-11-26       Impact factor: 4.792

Review 8.  Metabolites as regulators of insulin sensitivity and metabolism.

Authors:  Qin Yang; Archana Vijayakumar; Barbara B Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2018-10       Impact factor: 94.444

Review 9.  Gut microbial metabolites in obesity, NAFLD and T2DM.

Authors:  Emanuel E Canfora; Ruth C R Meex; Koen Venema; Ellen E Blaak
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

Review 10.  Human Gut Microbiome and Liver Diseases: From Correlation to Causation.

Authors:  Rui Li; Zhengsheng Mao; Xujun Ye; Tao Zuo
Journal:  Microorganisms       Date:  2021-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.